Vor Biopharma Inc.
NASDAQ:VORBiotechnology
Healthcare
$18.52 -2.26%
-$0.34 today
- Market cap
- $1.00B
- Beta
- 1.73
- P/E (TTM)
- -0.0
- EPS (TTM)
- -$2,053.13
52W Low $4.28High $65.80
Volume 0.83M
Average 1.07M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$371.64M
FY 2025 · Annual
Net Income
-$695.98M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 8.96M | 3.49M | 0 | 0 |
| Gross Profit | 0 | (8.96M) | (3.49M) | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 47.53M | 64.55M | 94.32M | 93.31M | 321.53M |
| Selling, General & Admin | 21.49M | 19.91M | 31.72M | 27.88M | 50.11M |
| Operating Expenses | 69.02M | 84.46M | 122.54M | 121.19M | 371.64M |
| Depreciation & Amortization | 1.43M | 8.96M | 3.49M | 3.53M | 2.89M |
| EBITDA | (67.47M) | (83.13M) | (114.37M) | (113.39M) | (693.09M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (69.02M) | (93.42M) | (126.04M) | (121.19M) | (371.64M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 119K | 1.32M | 8.17M | 4.27M | 5.87M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 119K | 1.32M | 8.17M | 4.27M | (324.34M) |
| Income Before Tax | (68.9M) | (92.09M) | (117.86M) | (116.91M) | (695.98M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (68.9M) | (92.09M) | (117.86M) | (116.91M) | (695.98M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (37.80) | (46.60) | (35.00) | (34.00) | (70.50) |
| EPS (Diluted) | (37.80) | (46.60) | (35.00) | (34.00) | (70.50) |
| 1.86M | 1.98M | 3.36M | 3.44M | 9.87M | |
| 1.86M | 1.98M | 3.36M | 3.44M | 9.87M |
VOR Earnings Waterfall · TTM
NASDAQ:VOR · Revenue to Net Income
Key Ratios
EPS$-838.86
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.0
P/S Ratio0.0
Analysis
$0 of revenue converted into -$883.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-838.86, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| 424B5 | 424B5 filing | Oct 30, 2026 | |
| 10-Q | Quarterly report | Oct 30, 2026 |
How much revenue does VOR generate?
Vor Biopharma Inc. (VOR) reported $0.00 of revenue in fiscal 2025.
Is VOR profitable?
Vor Biopharma Inc. (VOR) reported -$695.98M of net income.
Continue the stock analysis
Jump to another research area for this company.